As the U.S. stock market navigates a complex landscape marked by new tariffs and fluctuating corporate earnings, major indexes have still managed to post gains for January 2025. Amidst these developments, investors are increasingly on the lookout for stocks that may be trading below their estimated value, offering potential opportunities in an unpredictable environment. Identifying such stocks often involves assessing a company's fundamentals and market position relative to current economic conditions.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Click here to see the full list of 178 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

monday.com

Overview: monday.com Ltd. develops software applications globally, including in the United States, Europe, the Middle East, Africa, and the United Kingdom; it has a market cap of approximately $12.74 billion.

Operations: The company's revenue is primarily derived from its Internet Software & Services segment, totaling $906.59 million.

Estimated Discount To Fair Value: 25.3%

monday.com is trading at US$255.46, significantly below its estimated fair value of US$341.87, highlighting potential undervaluation based on cash flows. The company's revenue is expected to grow 18.4% annually, surpassing the broader U.S. market's growth rate of 8.8%. Recent expansions and strategic leadership changes further position monday.com for robust growth, despite recent quarterly net losses of US$12.03 million compared to a prior net income of US$7.49 million.

• Our earnings growth report unveils the potential for significant increases in monday.com's future results.
• Click here to discover the nuances of monday.com with our detailed financial health report.

Hims & Hers Health

Overview: Hims & Hers Health, Inc. operates a telehealth platform connecting consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally, with a market cap of approximately $8.14 billion.

Operations: The company generates revenue primarily through its online retailers segment, which amounts to $1.24 billion.

Estimated Discount To Fair Value: 45.8%

Hims & Hers Health is trading at US$37.28, significantly below its fair value estimate of US$68.8, indicating potential undervaluation based on cash flows. The company has become profitable this year, reporting a net income of US$75.59 million in Q3 2024 compared to a loss last year. Despite high share price volatility and insider selling, revenue growth outpaces the U.S. market, supported by strategic M&A and product expansions like meal replacements.

• In light of our recent growth report, it seems possible that Hims & Hers Health's financial performance will exceed current levels.
• Take a closer look at Hims & Hers Health's balance sheet health here in our report.

Snap

Overview: Snap Inc. is a technology company that operates in North America, Europe, and internationally with a market cap of approximately $18.94 billion.

Operations: The company's revenue primarily comes from its Software & Programming segment, which generated $5.17 billion.

Estimated Discount To Fair Value: 36.4%

Snap is trading at US$11.29, below its fair value estimate of US$17.76, suggesting potential undervaluation based on cash flows. Despite legal challenges concerning social media's impact on youth, Snap's revenue is expected to grow faster than the U.S. market at 11% annually, with profitability anticipated in three years. However, recent insider selling and low forecasted return on equity (12.9%) may warrant caution for investors evaluating long-term growth prospects amidst ongoing lawsuits.

• Our expertly prepared growth report on Snap implies its future financial outlook may be stronger than recent results.
• Click here and access our complete balance sheet health report to understand the dynamics of Snap.

Make It Happen

• Click here to access our complete index of 178 Undervalued US Stocks Based On Cash Flows.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGS:MNDY NYSE:HIMS and NYSE:SNAP.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com